CA
STJ

Cullinan Associates’s St Jude Medical STJ Stock Holding History

Cullinan Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,760
Closed -$1.53M – 208
2016
Q1 		$1.53M Buy
27,760
+4,000
+17% +$218K 0.13% 116
2015
Q4 		$1.47M Sell
23,760
-6,600
-22% -$416K 0.13% 114
2015
Q3 		$1.92M Buy
30,360
+860
+3% +$61.4K 0.17% 109
2015
Q2 		$2.16M Buy
29,500
+1,500
+5% +$108K 0.18% 107
2015
Q1 		$1.83M Buy
28,000
+5,900
+27% +$392K 0.14% 119
2014
Q4 		$1.44M Buy
22,100
+6,500
+42% +$419K 0.15% 70
2014
Q3 		$938K Sell
15,600
-2,000
-11% -$131K 0.11% 79
2014
Q2 		$803K Buy
17,600
+3,900
+28% +$253K 0.13% 72
2014
Q1 		$896K Sell
13,700
-300
-2% -$19.5K 0.1% 78
2013
Q4 		$867K Buy
14,000
+1,900
+16% +$110K 0.1% 78
2013
Q3 		$649K Sell
12,100
-6,600
-35% -$340K 0.09% 82
2013
Q2 		$853K Buy
+18,700
New +$810K 0.12% 76

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cullinan Associates's STJ Position: Q2 2016 in Review

Cullinan Associates sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 27,760 shares — an estimated $1.53M sold.

Cullinan Associates first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $2.16M in Q2 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Cullinan Associates reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Cullinan Associates sold 27,760 St Jude Medical shares in Q2 2016, an estimated $1.53M.
  • Cullinan Associates first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
  • Cullinan Associates's St Jude Medical position peaked at $2.16M in Q2 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Cullinan Associates's 13F filing for Q2 2016, filed 1 Jul 2016.